Pacira Pharmaceuticals Inc. (PCRX) Tumbled -8.85% or -4.1 To Price $42.25 On Thursday


Pacira Pharmaceuticals Inc. (PCRX) tumbled -8.85% or -4.1 to $42.25. It is near to 1.17 million shares traded, which is 175.89% compare to the average total volume 665718. The market cap of PCRX is $1.71 billion. The year to date change is 0.11%. The 52 week price range is from $29.81 to $58.95. Price of PCRX have changed 2.77% during last week. It have changed 5.46% over last month, 23.77% over last 3 months, -4.04% over last 6 months and 33.38% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PCRX is 41.02. It is -2.91% below current price. The 200-day Moving Averages for PCRX is 42.36. It is 0.26% above current price. The stock faces resistance at 200-day moving averages. The 52-week High is 58.95. It is 39.53% from the current price. The 52-week Low is 29.81. It is -29.44% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of PCRX is 6.65 on 2017-12-15. Short % to float is 11.52%. There are some statistics of PCRX. It is has market cap $1.71 billion. The share outstanding is 40.57 million. The average volume is 665718. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PCRX is -21.37%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PCRX is -10.37%.


Tags:

Share this post